Discover 3,573 paid clinical trials in Anaheim, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With research focusing on conditions such as chronic pain management, lymphoma, cardiovascular diseases, and mental health disorders, Anaheim offers many opportunities for both healthy volunteers and those looking for trials focused on specific health conditions. By joining a study, participants can access innovative treatment options and contribute to healthcare advancements in areas that matter most.
Filter
2
Filter results
Results: 3,573
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Pasadena CA, La Jolla CA, Stanford CA, San Francisco CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase 3, Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
for
Immunoglobulin G4 Related Disease
Location: Fontana CA, San Jose CA, Sacramento CA, Seattle WA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07190196
Phase 3, Recruiting
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
for
Prostate Carcinoma, Recurrent Prostate Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: Male
Age: 30 - 70+
Code: NCT07202247
Phase 2, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: La Palma CA, Long Beach CA, Newport Beach CA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Long Beach CA, Los Angeles CA, Northridge CA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Location: Los Angeles CA, Portland OR, Nashville TN, Tampa FL,
Sponsor: Orca Biosystems, Inc.
Sex: All
Age: 18+
Code: NCT07216443
Phase 2, Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Los Angeles CA, Stanford CA, San Francisco CA,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase 2, Phase 3, Recruiting
Cryoablation for Monomorphic Ventricular Tachycardia (VTS)
for
Ventricular Tachycardia, Sustained,
Location: Long Beach CA, Phoenix AZ, Nashville TN, Charleston SC,
Sponsor: Adagio Medical
Sex: All
Age: 18+
Code: NCT07650032
Recruiting
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
for
Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer,
Location: Los Angeles CA, La Jolla CA, Houston TX, Minneapolis MN,
Sponsor: Fate Therapeutics
Sex: All
Age: 18+
Code: NCT07216105
Phase 1, Recruiting
Dynamic Cervical Change: Prediction of Preterm Labor in Symptomatic Patients
for
Dynamic Cervical Change in Preterm Labor Patients
Location: Long Beach CA, Laguna Hills CA
Sponsor: Memorial Health Services Research Council
Sex: Female
Age: 18 - 45
Code: NCT00298480
Recruiting
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Los Angeles CA, Houston TX, Fayetteville AR,
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT07181161
Phase 1, Phase 2, Recruiting
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
for
Urothelial Cancer, Bladder Cancer
Location: Los Angeles CA, Dallas TX, Peoria IL, Niles IL,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07129993
Phase 2, Phase 3, Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: Duarte CA, Los Angeles CA, San Francisco CA, Houston TX,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase 1, Recruiting
Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
for
HIV
Location: Los Angeles CA, Providence RI
Sponsor: Westat
Sex: All
Age: 16 - 24
Code: NCT06444360
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for
Autoimmune Haemolytic Anaemia
Location: Los Alamitos CA, Duarte CA, Torrance CA, Los Angeles CA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07086976
Phase 3, Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
for
Type B Aortic Dissection
Location: Long Beach CA, Los Angeles CA, Phoenix AZ,
Sponsor: Duke University
Sex: All
Age: 21+
Code: NCT06087029
Recruiting
The Frequency of Screening and SBT Technique Trial: The FAST Trial
for
Critically Ill
Location: Long Beach CA, Ann Arbor MI, Hamilton, Toronto, Niagara,
Sponsor: Unity Health Toronto
Sex: All
Age: 16+
Code: NCT02969226
Recruiting
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment